Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection
Chang, JJY; Rawlinson, D; Pitt, ME; Taiaroa, G; Gleeson, J; Zhou, CX; Mordant, FL; De Paoli-Iseppi, R; Caly, L; Purcell, DFJ; Stinear, TP; Londrigan, SL; Clark, MB; Williamson, DA; Subbarao, K; Coin, LJM
(2021), Cell Reports
Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Features of Tumor Invasion and Down-Regulates C-Myc Expression in a Mouse Model of Colorectal Cancer Liver Metastasis
Riddiough, GE; Fifis, T; Walsh, KA; Muralidharan, V; Christophi, C; Tran, BM; Vincan, E; Perini, MV
(2021), Cancers
Antibody Dynamics for Plasmodium vivax Malaria: A Mathematical Model
Mehra, S; McCaw, JM; Flegg, MB; Taylor, PG; Flegg, JA
(2021), Bull. Math. Biol.
Weight shapes the intestinal microbiome in preterm infants: results of a prospective observational study
Heida, FH; Kooi, EMW; Wagner, J; Nguyen, TY; Hulscher, JBF; van Zoonen, AGJF; Bos, AF; Harmsen, HJM; de Goffau, MC
(2021), BMC Microbiol.
Modelling testing and response strategies for COVID-19 outbreaks in remote Australian Aboriginal communities
Hui, BB; Brown, D; Chisholm, RH; Geard, N; McVernon, J; Regan, DG
(2021), BMC Infect. Dis.
Why Does Hyperuricemia Not Necessarily Induce Gout?
Zhang, WZ
(2021), Biomolecules
DOI: 10.3390/biom11020280
Spatial mapping of gonorrhoea notifications by sexual practice in Victoria, Australia, 2017-2019
Chow, EPF; Fairley, CK; Williamson, DA; Chen, MY
(2021), Aust. N. Z. Publ. Health, 672-674
Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B
Khlaiphuengsin, A; Chuaypen, N; Hirankarn, N; Avihingsanon, A; Crane, M; Lewin, SR; Tangkijvanich, P
(2021), Asian Pac. J. Allergy Immunol., 129-135
Genomic Epidemiology and Antimicrobial Resistance Mechanisms of Imported Typhoid in Australia
Ingle, DJ; Andersson, P; Valcanis, M; Wilmot, M; Easton, M; Lane, C; Barden, J; da Silva, AG; Seemann, T; Horan, K; Ballard, SA; Sherry, NL; Williamson, DA; Howden, BP
(2021), Antimicrob. Agents Chemother.
DOI: 10.1128/AAC.01200-21
Clinical Relevance of Topical Antibiotic Use in Coselecting for Multidrug-Resistant Staphylococcus aureus: Insights from In Vitro and Ex Vivo Models
Nong, Y; Taiaroa, G; Pasricha, S; Guerillot, R; Monk, IR; Baines, SL; Carter, GP; Howden, BP; Williamson, DA
(2021), Antimicrob. Agents Chemother.
DOI: 10.1128/AAC.02048-20
Infrared Based Saliva Screening Test for COVID-19
Wood, BR; Kochan, K; Bedolla, DE; Salazar-Quiroz, N; Grimley, SL; Perez-Guaita, D; Baker, MJ; Vongsvivut, J; Tobin, MJ; Bambery, KR; Christensen, D; Pasricha, S; Eden, AK; Mclean, A; Roy, S; Roberts, JA; Druce, J; Williamson, DA; McAuley, J; Catton, M; Purcell, DFJ; Godfrey, DI; Heraud, P
(2021), Angew. Chem.-Int. Edit., 17102-17107
The Causal Interpretation of Overall Vaccine Effectiveness in Test-Negative Studies
Feng, S; Sullivan, SG; Tchetgen, EJT; Cowling, BJ
(2021), Am. J. Epidemiol., 1993-2014
DOI: 10.1093/aje/kwab101
Scoping review: hotspots for COVID-19 urological research: what is being published and from where?
Qu, LG; Perera, M; Lawrentschuk, N; Umbas, R; Klotz, L
(2021), World J. Urol., 3151-3160
A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer
Holmes, A; Kelly, BD; Perera, M; Eapen, RS; Bolton, DM; Lawrentschuk, N
(2021), World J. Urol., 297-306
Ga-68-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial
Bowden, P; See, AW; So, K; Lawrentschuk, N; Moon, D; Murphy, DG; Rao, R; Crosthwaite, A; King, D; Haxhimolla, H; Grummet, J; Ruljancich, P; Gyomber, D; Landau, A; Campbell, N; Frydenberg, M; Smyth, LML; Nolan, S; Gwini, SM; McKenzie, DP
(2021), World J. Urol., 4117-4125
Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer
Degeling, K; Corcoran, NM; Pereira-Salgado, A; Hamid, AA; Siva, S; IJzerman, MJ
(2021), Value Health, 1737-1745
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey
Fine, SW; Trpkov, K; Amin, MB; Algaba, F; Aron, M; Baydar, DE; Beltran, AL; Brimo, F; Cheville, JC; Colecchia, M; Comperat, E; Costello, T; da Cunha, IW; Delprado, W; DeMarzo, AM; Giannico, GA; Gordetsky, JB; Guo, CC; Hansel, DE; Hirsch, MS; Huang, JT; Humphrey, PA; Jimenez, RE; Khani, F; Kong, MX; Kryvenko, ON; Kunju, LP; Lal, P; Latour, M; Lotan, T; Maclean, F; Magi-Galluzzi, C; Mehra, R; Menon, S; Miyamoto, H; Montironi, R; Netto, GJ; Nguyen, JK; Osunkoya, AO; Parwani, A; Pavlovich, CP; Robinson, BD; Rubin, MA; Shah, RB; So, JS; Takahashi, H; Tavora, F; Tretiakova, MS; True, L; Wobker, SE; Yang, XMJ; Zhou, M; Zynger, DL; Epstein, JI
(2021), Urol. Oncol.-Semin. Orig. Investig.
Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution
Anderson, E; Smyth, LML; O'Sullivan, R; Ryan, A; Lawrentschuk, N; Grummet, J; See, AW
(2021), Transl. Androl. Urol., 3591-3603
DOI: 10.21037/tau-21-508
Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer-a narrative review
Ong, S; O'Brien, J; Medhurst, E; Lawrentschuk, N; Murphy, D; Azad, A
(2021), Transl. Androl. Urol., 3918-3930
DOI: 10.21037/tau-20-1118
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
McCoy, P; Mangiola, S; Macintyre, G; Hutchinson, R; Tran, B; Pope, B; Georgeson, P; Hong, MKH; Kurganovs, N; Lunke, S; Clarkson, MJ; Cmero, M; Kerger, M; Stuchbery, R; Chow, K; Haviv, I; Ryan, A; Costello, AJ; Corcoran, NM; Hovens, CM
(2021), Prostate Cancer Prostatic Dis., 1167-1180
Irreversible Electroporation for Prostate Cancer
Ong, S; Leonardo, M; Chengodu, T; Bagguley, D; Lawrentschuk, N
(2021), Life-Basel
DOI: 10.3390/life11060490
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center Study
Furrer, MA; Kiss, B; Studer, UE; Wuethrich, PY; Gahl, B; Seiler, R; Roth, B; Bosshard, P; Thomas, BC; Burkhard, FC; Boxler, S; Thalmann, GN
(2021), J. Urol., 1629-1640
Patterns of primary staging for newly diagnosed prostate cancer in the era of prostate specific membrane antigen positron emission tomography: A population-based analysis
Papa, N; Perera, M; Murphy, DG; Lawrentschuk, N; Evans, M; Millar, JL; Bolton, D
(2021), J. Med. Imag. Radiat. Oncol., 649-654
Predictors for Perioperative Blood Transfusion in Patients Undergoing Open Cystectomy and Urinary Diversion and Development of a Nomogram: An Observational Cohort Study
Engel, D; Beilstein, CM; Jerney, P; Furrer, MA; Burkhard, FC; Loffel, LM; Wuethrich, PY
(2021), J. Clin. Med.
DOI: 10.3390/jcm10132797
Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
Cmero, M; Kurganovs, NJ; Stuchbery, R; McCoy, P; Grima, C; Ngyuen, A; Chow, K; Mangiola, S; Macintyre, G; Howard, N; Kerger, M; Dundee, P; Ruljancich, P; Clarke, D; Grummet, J; Peters, JS; Costello, AJ; Norden, S; Ryan, A; Parente, P; Hovens, CM; Corcoran, NM
(2021), JCO Precis. Oncol., 1048-1059
DOI: 10.1200/PO.20.00337
The role of PSMA PET/CT imaging in the diagnosis, staging and restaging of prostate cancer
Bagguley, D; Ong, S; Buteau, JP; Koschel, S; Dhiantravan, N; Hofman, MS; Emmett, L; Murphy, DG; Lawrentschuk, N
(2021), Future Oncol., 2225-2241
The application of theranostics in different stages of prostate cancer
Alghazo, O; Eapen, R; Koschel, S; Cumberbatch, M; Buteau, J; Loh, R; Lawrentschuk, N; Murphy, DG
(2021), Future Oncol., 3637-3644
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm(3) and 80-150-cm(3) Prostates
Nguyen, DD; Barber, N; Bidair, M; Gilling, P; Anderson, P; Zorn, KC; Badlani, G; Humphreys, M; Kaplan, S; Kaufman, R; So, A; Paterson, R; Goldenberg, L; Elterman, D; Desai, M; Lingeman, J; Roehrborn, C; Bhojani, N
(2021), Eur. Urol. Open Sci., 21-28
Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review
Degeling, K; Pereira-Salgado, A; Corcoran, NM; Boutros, PC; Kuhn, P; IJzerman, MJ
(2021), Eur. Urol. Open Sci., 77-87
Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer
Furrer, MA; Grueter, T; Bosshard, P; Vartolomei, MD; Kiss, B; Thalmann, GN; Roth, B
(2021), Eur. Urol. Focus, 1052-1060